Show simple item record

dc.contributor.author
Bai, Peng
dc.contributor.supervisor
Fussenegger, Martin
dc.contributor.supervisor
Benenson, Yaakov
dc.contributor.supervisor
Stelling, Jörg
dc.date.accessioned
2020-04-14T08:25:09Z
dc.date.available
2020-04-11T21:03:58Z
dc.date.available
2020-04-14T08:25:09Z
dc.date.issued
2019
dc.identifier.uri
http://hdl.handle.net/20.500.11850/409295
dc.identifier.doi
10.3929/ethz-b-000409295
dc.description.abstract
Mammalian synthetic biology aims to program and probe mammalian cell behavior in order to achieve novel or desirable functionalities. Advances in this field have led to a variety of sophisticated synthetic biological components and systems that opened up many new doors for the development of novel gene- and cell-based therapeutic and diagnostic products as alternative strategies to conventional medicine. However, when translating these gene- and cell-based products into humans, one significant issue to be considered is the potential immunogenicity, even with encapsulated cellular implants. For example, the xeno-antigens may trigger host immune response and affect the products’ safety and efficacy after transplantation. Since the human body itself owns a library of receptors for detecting changes in its physiological state or for detecting external stimuli, we can take advantage of our own sensing molecules as a rich resource for the design of synthetic gene networks and therapeutic products that are immune-compatible. To fulfill this aim, this thesis is dedicated to exploring the potential of using human receptors as core-building blocks for cell- and gene- based therapy to solve real-world medical problems. In this work, the individual chapters will illustrate two detailed examples on how to rewire human receptor-based signaling pathways for engineering cell therapeutics: (1) A closed-loop synthetic gene circuit using human bile acid receptor TGR5 as a sensor for liver injury, providing early detection of liver injury and performing automatic treatment; (2) An open-loop synthetic gene circuit using human menthol and cold receptor TRPM8 for the construction of a fully human transgene switch to regulate therapeutic release via cooling sensation. Finally, a conclusion is drawn to discuss the advantages and disadvantages of the current work as well as its potential in future development and for the translation from bench to bedside.
en_US
dc.format
application/pdf
en_US
dc.language.iso
en
en_US
dc.publisher
ETH Zurich
en_US
dc.rights.uri
http://rightsstatements.org/page/InC-NC/1.0/
dc.title
Biosensor-based cell therapies for the treatment of experimental liver injury, muscle atrophy and diabetes
en_US
dc.type
Doctoral Thesis
dc.rights.license
In Copyright - Non-Commercial Use Permitted
dc.date.published
2020-04-14
ethz.size
129 p.
en_US
ethz.code.ddc
DDC - DDC::6 - Technology, medicine and applied sciences::600 - Technology (applied sciences)
en_US
ethz.code.ddc
DDC - DDC::5 - Science::570 - Life sciences
en_US
ethz.code.ddc
DDC - DDC::6 - Technology, medicine and applied sciences::610 - Medical sciences, medicine
en_US
ethz.identifier.diss
26071
en_US
ethz.publication.place
Zurich
en_US
ethz.publication.status
published
en_US
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02060 - Dep. Biosysteme / Dep. of Biosystems Science and Eng.::03694 - Fussenegger, Martin / Fussenegger, Martin
en_US
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02060 - Dep. Biosysteme / Dep. of Biosystems Science and Eng.::03694 - Fussenegger, Martin / Fussenegger, Martin
en_US
ethz.date.deposited
2020-04-11T21:04:08Z
ethz.source
FORM
ethz.eth
yes
en_US
ethz.availability
Open access
ethz.date.embargoend
2023-04-14
ethz.rosetta.installDate
2020-04-14T08:25:20Z
ethz.rosetta.lastUpdated
2024-02-02T10:43:19Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=Biosensor-based%20cell%20therapies%20for%20the%20treatment%20of%20experimental%20liver%20injury,%20muscle%20atrophy%20and%20diabetes&rft.date=2019&rft.au=Bai,%20Peng&rft.genre=unknown&rft.btitle=Biosensor-based%20cell%20therapies%20for%20the%20treatment%20of%20experimental%20liver%20injury,%20muscle%20atrophy%20and%20diabetes
 Search print copy at ETH Library

Files in this item

Thumbnail
Thumbnail

Publication type

Show simple item record